Company Overview and News

0
Standard & Poor's says cobalt supply fears remain high

2018-07-20 proactiveinvestors.com.au
Standard & Poor's believes risks remain high around the supply of ethically sourced cobalt from the world’s largest producer, Democratic Republic of Congo (DRC).
BPL CFE CMULF BPLNF

0
Broken Hill and Cobalt Blue’s Thackaringa JV of ‘global significance’

2018-07-05 australianmining.com.au
Broken Hill Prospecting’s joint Thackaringa cobalt project with Cobalt Blue has received strong results from its pre-feasibility study (PFS), indicating the project to be low-cost, high-purity, globally significant source of cobalt sulphate.
BPL BPLNF

0
Broken Hill Prospecting confirms robust pre-feasibility results for Thackaringa Cobalt Project

2018-07-04 proactiveinvestors.com.au
Broken Hill Prospecting Ltd (ASX:BPL) has received positive pre-feasibility study results and a maiden ore reserve estimate for the Thackaringa Cobalt Project near Broken Hill in New South Wales.
BPL BPLNF

0
Cobalt Blue Holdings’ PFS justifies proceeding towards commercial development of Thackaringa

2018-07-04 proactiveinvestors.com.au
Cobalt Blue Holdings Ltd (ASX:COB) has received positive results from a pre-feasibility study (PFS) into the Thackaringa Cobalt Project near Broken Hill that justify proceeding towards commercial development.
BPL BPLNF

0
Broken Hill Prospecting granted trading halt pending cobalt project PFS

2018-07-02 proactiveinvestors.com.au
Broken Hill Prospecting Ltd (ASX:BPL) has been granted a trading halt pending the release of a pre-feasibility study on the Thackaringa Cobalt Project of joint venture partner Cobalt Blue Holdings Ltd (ASX:COB).
BPL BPLNF

0
Cobalt Blue Holdings to release ore reserve estimate and PFS for Thackaringa Cobalt Project

2018-07-02 proactiveinvestors.com.au
Cobalt Blue Holdings Ltd (ASX:COB) will this week release its first ore reserve estimate and finalised pre-feasibility study (PFS) for the Thackaringa Cobalt Project at Broken Hill.
VBS BPL BPLNF AEI

0
Cobalt Blue Holdings thanks Trangie Johnston for board participation

2018-06-19 proactiveinvestors.com.au
Cobalt Blue Holdings Ltd (ASX:COB) has a change in the board, with Trangie Johnston resigning as a non-executive director to focus on his managing director position at Broken Hill Prospecting Ltd (ASX:BPL).
BPL BPLNF

0
The Broken Hill District May Grow To Become Australia's Premiere Cobalt Mining Center

2018-06-11 seekingalpha
The Broken Hill surrounding district is showing signs of becoming a world class cobalt sulphide mining region.
AUZ CLQ CCZ AYR HAV BPL AMSLF BPLNF

0
Ausmon Resources up 40% after being granted tenements near Broken Hill prospective for cobalt

2018-05-18 proactiveinvestors.com.au
Ausmon Resources Ltd (ASX:AOA) is a leading ASX gainer on news of the grant of two exploration licences near Broken Hill prospective for cobalt.
AUZ BPL AOA AMSLF BPLNF

7
Top 6 Cobalt Junior Developer Miners To Boom By 2021/2022

2018-05-17 seekingalpha
Six cobalt junior developers can each produce ~5,000 tonnes pa of cobalt by 2021/22. These companies each have the potential to be worth ~AUD 3b if cobalt prices remain strong.
CLA CCZ HAV GLCNF ECSIF CZI AMSLF BPLNF POS HIG AUZ RNX RNKLF GME AQR FT PSDNF AYR AEOMF KATFF RNX.WT FTMDF KAT CNJ BPL HLPCF CSSQF

0
Broken Hill Prospecting adds to mineral sands ground and is the Murray Basin’s largest tenement holder

2018-05-08 proactiveinvestors.com.au
Broken Hill Prospecting Ltd (ASX:BPL) has been granted four new exploration licences which firmly establishes its position as the largest mineral sands tenement holder in the Murray Basin.
BPL BPLNF

0
Castillo Copper’s cobalt shares same geology as Cobalt Blue’s Thackaringa deposit

2018-05-01 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has identified six cobalt prospects near Broken Hill with the same geological sequence as the nearby Thackaringa deposit of Cobalt Blue Holdings Ltd (ASX:COB).
CCZ AXE BPL BPLNF

0
Cobalt Blue Holdings retains 51% beneficial ownership of Thackaringa Cobalt Project

2018-04-20 proactiveinvestors.com.au
Cobalt Blue Holdings Ltd (ASX:COB) has retained its 51% beneficial ownership in the Thackaringa Cobalt Project Joint Venture after completing stage I earn-in requirements.
BPL BPLNF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:BPL / BROKEN HILL PROSPECTING LIMITED on message board site Silicon Investor.

Broadband over power lines-BPL : 1) TELKONET -TKO u0026 2) AMBIE Bank Plus (BPLS)
Bio Plexus, Inc. BPLX Barrington Petroleum...BPL:tse